David Gregornik, BA, BS, PharmD
Residency, St Jude Children's Research Hospital
BA Psychology, University of Minnesota
BS Pharmacy, University of Minnesota
Licensures and Certifications
David Gregornik is the Pharmacogenomics Program Director at Children's Minnesota. Dr. Gregornik attended the University of Minnesota College of Pharmacy where he earned his Bachelor of Science in Pharmacy and his PharmD (1994). In 1995 he completed a specialty residency in Pediatric Pharmacotherapy at St. Jude Children's Research Hospital in Memphis TN.
Dr. Gregornik was part of the St Jude Pharmaceutical Department for 18 years providing advanced clinical pharmacy care to children with cancer and undergoing bone marrow transplant.
From 2009-2013 David moved to Memorial-Sloan Kettering Cancer Center where he served as Manager of Pediatric Clinical Pharmacy Programs. Dr. Gregornik joined Children's Minnesota in August 2016 where he established a Pharmacogenomics Clinical Service and ambulatory clinic.
His research areas include clinical pharmacogenomics implementation and evaluating pharmacogenomic determinants of response and toxicity in children with cancer.
Pharmacogenomics clinical implementation, pediatric oncology and assessment of renal function in children
Clinical Implementation of Pharmacogenomics
Pharmacogenomics, TDM of thiopurines during treatment for pediatric ALL